Search Results - N. V. Perova

Refine Results
  1. 1
    Omega-3 polyunsaturated fatty acids in cardiology

    Omega-3 polyunsaturated fatty acids in cardiology by N. V. Perova

    Published 2005-08-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    REDUCTION DEGREE OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL LEVELS ACCORDING TO DIFFERENT DOSES OF STATINS; ITS EFFECT ON THE RISK OF ISCHEMIC HEART DISEASE ACUTE EPISODES DEPENDING ON TREATMENT DURATION; AND RISK OF ISCHEMIC AND THROMBOEMBOLIC STROKE. COMMENT ON THE PAPER OF LAW M.R., WALD N.J., RUDNICKA A.R. QUANTIFYING EFFECT OF STATINS ON LOW DENSITY LIPOPROTEIN CHOLESTEROL, ISCHAEMIC HEART DISEASE, AND STROKE: SYSTEMATIC REVIEW AND META-ANALYSIS. BMJ 2003; 326:1423-1427

    REDUCTION DEGREE OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL LEVELS ACCORDING TO DIFFERENT DOSES OF STATINS; ITS EFFECT ON THE RISK OF ISCHEMIC HEART DISEASE ACUTE EPISODES DEPENDING O... by N. V. Perova

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Plant stanol ethers: perspectives and effects in non-pharmaceutical prevention of atherosclerotic cardiovascular pathology

    Plant stanol ethers: perspectives and effects in non-pharmaceutical prevention of atherosclerotic cardiovascular pathology by N. V. Perova

    Published 2006-12-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    EFFECT OF CHOLESTEROL BLOOD LEVEL REDUCTION BEGINNING EARLY IN LIFE ON THE RISK OF ISCHEMIC HEART DISEASE

    EFFECT OF CHOLESTEROL BLOOD LEVEL REDUCTION BEGINNING EARLY IN LIFE ON THE RISK OF ISCHEMIC HEART DISEASE by N. V. Perova

    Published 2015-09-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Non-pharmaceutical hypercholesterolemia management by plant stanol-enriched product consumption

    Non-pharmaceutical hypercholesterolemia management by plant stanol-enriched product consumption by N. V. Perova

    Published 2006-10-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Moral Agency Conditions: Moral Agent, Limited Moral Agent, Quasi-Moral Agent

    Moral Agency Conditions: Moral Agent, Limited Moral Agent, Quasi-Moral Agent by S. V. Glebova, N. V. Perova

    Published 2023-09-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME

    RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME by N. V. Perova, V. A. Metelskaya

    Published 2015-09-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Postprandial hyperglycemia and cardiovascular events. Acarbose therapy in patients with coronary heart disease and impaired carbohydrate metabolism

    Postprandial hyperglycemia and cardiovascular events. Acarbose therapy in patients with coronary heart disease and impaired carbohydrate metabolism by N. A. Logunova, M. G. Bubnova, N. V. Perova

    Published 2008-10-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Plant sterols and stanols as dietary factors reducing hypercholesterolemia by inhibiting intestinal cholesterol absorption

    Plant sterols and stanols as dietary factors reducing hypercholesterolemia by inhibiting intestinal cholesterol absorption by M. A. Khuchieva, N. V. Perova, N. M. Akhmedzhanov

    Published 2011-12-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS

    METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS by N. V. Perova, I. N. Ozerova, V. A. Metelskaya

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK

    EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK by N. V. Perova, E. I. Sokolov, G. N. Shchukina, V. A. Metelskaya

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Gender specifics of the association between blood fibrinolytic activity and cardiovascular disease or diabetes mellitus in a cohort of Muscovites aged 55 years or older

    Gender specifics of the association between blood fibrinolytic activity and cardiovascular disease or diabetes mellitus in a cohort of Muscovites aged 55 years or older by L. A. Ratnikova, V. A. Metelskaya, N. V. Perova, A. D. Deev, S. A. Shalnova

    Published 2012-08-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    SUBFRACTIONAL SPECTRUM OF HIGH DENSITY LIPOPROTEIDS IN CORONARY ATHEROSCLEROSIS PATIENTS

    SUBFRACTIONAL SPECTRUM OF HIGH DENSITY LIPOPROTEIDS IN CORONARY ATHEROSCLEROSIS PATIENTS by I. N. Ozerova, V. A. Metelskaya, N. V. Perova, N. E. Gavrilova, S. A. Boytsov

    Published 2015-04-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    Combined lipid-lowering and antihypertensive therapy effects on hemostasis in metabolic sydrome patients

    Combined lipid-lowering and antihypertensive therapy effects on hemostasis in metabolic sydrome patients by L. A. Ratnikova, V. A. Metelskaya, M. N. Mamedov, O. V. Kosmatova, N. V. Perova

    Published 2006-04-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND VARYING DEGREE OF CORONARY STENOSIS

    LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND VARYING DEGREE OF CORONARY STENOSIS by I. N. Ozerova, N. V. Perova, V. A. Metelskaya, O. I. Chernushevich, N. E. Gavrilova

    Published 2013-08-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Lipid profile stability and prognostic value in adolescents: 22-year prospective study

    Lipid profile stability and prognostic value in adolescents: 22-year prospective study by V. B. Rozanov, A. A. Alexandrov, N. V. Perova, E. N. Shugaeva, E. Yu. Zvolinskaya

    Published 2007-10-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    Platelet aggregation, dyslipoproteinemia and polyunsaturated fatty acids

    Platelet aggregation, dyslipoproteinemia and polyunsaturated fatty acids by E. I. Sokolov, V. A. Metelskaya, N. V. Perova, G. N. Shchukina, V. M. Fomina

    Published 2006-10-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    Experimental in vitro Comparative Study of Chromovitectomy Agents Cyto- and Phototoxicity

    Experimental in vitro Comparative Study of Chromovitectomy Agents Cyto- and Phototoxicity by N. M. Kislitsyna, S. V. Novikov, N. V. Perova, S. V. Kolesnik, A. I. Kolesnik, M. P. Veselkova

    Published 2020-09-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES

    DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES by N. V. Perova, V. A. Metel'skaya, E. I. Sokolov, G. N. Shchukina, V. M. Fomina

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    FACTOR ANALYSIS AND INDIVIDUAL PROGNOSIS FOR THE PATIENTS WITH FIRST REVEALED ARTERIAL HYPERTENSION

    FACTOR ANALYSIS AND INDIVIDUAL PROGNOSIS FOR THE PATIENTS WITH FIRST REVEALED ARTERIAL HYPERTENSION by N. E. Gavrilova, V. A. Metelskaya, N. V. Perova, E. B. Yarovaya, S. A. Boytsov, V. P. Mazaev

    Published 2014-06-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: